Top Markets
#1 MowCat MowCat +526.85%
#2 龙虾 (Lobster) 龙虾 (Lobster) +87.16%
#3 Magma Finance Magma Finance +40.75%
#4 Akedo Akedo +36.23%
#5 SIXSEVEN SIXSEVEN +30.35%
#6 Cortex Cortex +25.50%
#7 DeXe DeXe +16.75%
#8 OpenEden OpenEden +16.58%
#9 Pons Pons +15.57%
#10 MarsCoin MarsCoin +13.89%
Coin of the day
MowCat MowCat
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Staidson (Beijing) BioPharmaceuticals Co., Ltd. Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Staidson (Beijing) BioPharmaceuticals Co., Ltd.

300204
Pozycja w akcjach #7952
Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical... Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical company that specializes in the entire lifecycle of therapeutic drugs, from research and development to production and market distribution. Their product portfolio encompasses a variety of drug types, including advanced protein-based medicines like therapeutic monoclonal antibodies, innovative gene and cell therapies, and conventional chemical pharmaceuticals. The company's primary therapeutic areas address conditions related to the nervous system, infectious diseases, gastrointestinal health, the urinary system, and autoimmune disorders. Notably, Staidson has established a strategic partnership with Pivotal S.L. to conduct clinical trials in Europe for BDB-001, a monoclonal anti-C5a antibody, aimed at treating patients with severe, progressive COVID-19 caused by the SARS-CoV-2 virus. Founded in 2002, the company's headquarters are located in Beijing, China.
Cena akcji
$3.11
Kapitalizacja rynkowa
$1.41B
Zmiana (1 dzień)
-1.97%
Zmiana (1 rok)
-57.22%
Kraj
CN
Handel Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)

Kategoria

Healthcare
Zyski dla Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Staidson (Beijing) BioPharmaceuticals Co., Ltd., obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Staidson (Beijing) BioPharmaceuticals Co., Ltd. od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH